Start a New Search
SHOWING 176 RESULTS
A genomic screening approach of more than 50,000 people shows that more than 80 percent of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don’t know it despite frequent interaction with the healthcare system.
University Research | Yale UniversityA drug therapy used for patients with chronic heart failure also improves markers of poor prognosis in individuals who are hospitalized with acute heart failure, new Yale-led research shows.
University Research | Yale UniversityThe gene editing technology CRISPR has prompted both breathless predictions of medical breakthroughs and warnings of the apocalypse. Dr. Greg Licholai, a biotech entrepreneur and a lecturer at Yale explains CRISPR’s potential and dangers.
University Research | Yale UniversityIn a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection.
University Research | Yale UniversityTesting for dozens of genetic mutations in tumors of patients with a common form of advanced lung cancer did not appear to improve survival compared to routine genetic testing, a study led by Yale Cancer Center (YCC) scientists has found.
University Research | Yale UniversityYale researchers uncovered an unexpected function for the gene known as Nucleobindin-2 (Nucb2) in reducing inflammation.
University Research | Yale UniversityA Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine.
University Research | Yale UniversityA new Yale-led international study of individuals with alcohol dependence has identified gene variants that may help explain why some heavy drinkers suffer intense withdrawal symptoms when they try to stop drinking — some, less so.
University Research | Yale UniversityNew “Robotic Skins” technology developed by Yale researchers allows users to animate the inanimate and turn everyday objects into robots.
University Research | Yale UniversityThe combination of naltrexone and ketamine can help treat both symptoms of addiction and depression, a preliminary study by Yale University researchers suggests.
University Research | Yale University